The FDA said it will grant some patients early access to Revolution Medicines' experimental pancreat...
FDA green lights early access to pancreatic cancer drug, daraxonrasib
The FDA said it will grant some patients early access to Revolution Medicines' experimental pancreatic cancer drug daraxonrasib.
Author: USA Today
Read Original Article